In this webinar, Dr. Sophie Pezet and Dr. Benjamin Vidal discuss methodology, applications and new possibilities enabled by functional ultrasound (fUS) imaging, with a focus on chronic pain and neuropharmacology research.

Sophie Pezet, PhD: Functional Ultrasound Imaging: a novel approach for the study of pain mechanisms

While acute pain is useful in alerting the body to noxious stimulation, chronic pain is always deleterious. Most chronic pain arises from abnormal neuronal plasticity due to a previous condition, such as peripheral inflammation (inflammatory pain) or a nerve lesion (neuropathic pain). Dr. Sophie Pezet illustrates the use of fUS to study the alterations of cerebral networks in two animal models of inflammatory pain. She also presents a recent study analyzing the vascularization of the spinal cord in rats, and re-evaluating a fundamental mechanism of acute pain and peripheral sensitization using neurovascular coupling in the spinal cord. These studies open the way for future pharmacological studies aiming at the development of new analgesic treatments.

Benjamin Vidal, PharmD, PhD: Imaging acute effects of drugs in the brain using pharmaco-fUS in rodents

Functional ultrasound (fUS) is a new neuroimaging technique able to follow changes in cerebral blood volume without any contrast agent at high spatiotemporal resolution. In this webinar, Dr. Benjamin Vidal presents different pharmaco-fUS experiments measuring the acute hemodynamic effects of drugs as a way to understand their regional and temporal impact on brain activity. Dr. Vidal also shows how pharmaco-fUS enables the direct measurement of changes in cerebral blood volume or functional connectivity, providing access to rich pharmacological information thanks to different analysis strategies.

Key Topics Include:

  • Methodology of fUS and pharmaco-fUS experiments
  • How fUS compares to other neuroimaging techniques: sensitivity, versatility and current challenges
  • What is the feasibility of fUS in anaesthetized or awake animals, and how does it compare to other in vivo neuroimaging methods?
  • What information does fUS provide to address neurobiological questions and to understand drugs’ effects?
  • How does pharmaco-fUS differ from other fUS experiments (resting state or sensory stimulation/task-based paradigms)?

Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video viewer.


To retrieve a PDF copy of the presentation, click on the link below the slide player. From this page, click on the “Download” link to retrieve the file.


Associate Professor
Physics for Medicine, Paris
Ecole Supérieure de Physique et Chimie Industrielles

Sophie Pezet is a Neurobiologist, working on the cellular and molecular mechanisms underlying pain maintenance. She produced a significant contribution in the understanding of the role of some neurotrophic factors such as BDNF (Brain-Derived Neurotrophic Factor)  in the spinal cord, in inflammatory and neuropathic pain. Her team is using molecular, behavioral and imaging approaches to improve our understanding of (physiological) acute pain, but also altered brain and spinal functions in chronic pain disorders.

Research Engineer

Benjamin Vidal is a research engineer for the biopharmaceutical company Theranexus, which is developing innovative drug candidates to be used in the treatment of CNS disorders. He is using in vivo neuroimaging techniques such as positron emission tomography, functional magnetic resonance imaging and functional ultrasound in order to study brain pharmacology and animal models of neurological diseases.

Production Partner


We are committed to delivering unparalleled neuro functional imaging tools to the scientific community. Helping researchers worldwide to shed light on the brain and central nervous system and better understand the associated pathologies to progress toward  effective treatments.

Additional Content From Iconeus

Related Content